Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin plus superpotent topical corticosteroid in bullous pemphigoid
DRKS00003851Phase 2Terminated
- Sponsor
- Philipps-Universität Marburg
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Bullous Pemphigoid (BP) comparing Clobetasol + placebo with Clobetasol + simvastatin (2 arms). Started Apr 2013; status: terminated.
02
Drugs
simvastatin
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on DRKS00003851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003851.